Progenics Pharmaceuticals Inc. (PGNX) surged 8.23% or 0.42 to $5.46. It is approximately 1.81 million shares traded, which is 119.01% compare to the average total volume 1.52 million. The market cap of PGNX is $461.18 million. The year to date change is 26.82%. The 52 week price range is from $3.62 to $9.42. Price of PGNX have changed 3.07% during last week. It have changed 25.37% over last month, 7.01% over last 3 months, -14.86% over last 6 months and -29.51% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PGNX is 4.55. It is -16.67% below current price. The 200-day Moving Averages for PGNX is 5.85. It is 7.14% above current price. The 52-week High is 9.42. It is 72.53% from the current price. The 52-week Low is 3.62. It is -33.70% from current price.
There are some statistics of PGNX. It is has market cap $461.18 million. The share outstanding is 84.54 million. The average volume is 1.52 million. The percent of top 15 Institution holding is 125.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PGNX is -83.62%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PGNX is -43.76%.